Crosslinked type II collagen matrices: preparation, characterization, and potential for cartilage engineering

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Cartilage Repair

Background:

• Articular cartilage has limited self-repair capabilities, driving research into tissue engineering.
• Type II collagen and chondroitin sulfate (CS) are key components of hyaline cartilage, offering potential for engineered cartilage.
• Developing suitable matrices is crucial for regenerating cartilage-like tissue.

Purpose of the Study:

• To prepare and characterize type II collagen matrices with and without CS.
• To evaluate the ability of these matrices to support chondrocyte proliferation and differentiation in vitro.
• To compare the performance of type II collagen matrices with type I collagen matrices.

Main Methods:

• Purified, pepsin-treated type II collagen was used to create matrices.
• Crosslinking and CS covalent attachment were achieved using 1-ethyl-3-(3-dimethyl aminopropyl)carbodiimide.
• Matrices were characterized for physico-chemical properties and evaluated in vitro with chondrocytes using biochemical and molecular analyses.

Main Results:

• Type II collagen matrices supported chondrocyte distribution throughout the matrix, unlike type I collagen.
• Engineered matrices developed a cartilaginous-like surface layer and internal cell clusters after 14 days.
• Chondrocytes exhibited proliferation and differentiation, confirmed by various assays, with no significant impact of CS presence.

Conclusions:

• Type II collagen matrices are suitable scaffolds for cartilage tissue engineering.
• These matrices effectively support chondrocyte behavior, leading to cartilage-like tissue formation.
• Chondroitin sulfate incorporation did not provide significant additional benefits in this in vitro model.